New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones - Test2 - elhamkhani - TriplyDB

New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones

New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones

http://www.wikidata.org/entity/Q28068142

about

Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises.Endoplasmic Reticulum Protein Quality Control Failure in Myelin Disorders.

P2860

Q38652950-43C32690-1687-4D79-839C-08AD49604033 Q39094240-828A53BE-C847-4498-A562-3A35AED9CF63

P2860

New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones

http://www.wikidata.org/entity/Q28068142

description

2016 nî lūn-bûn

@nan

2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

New therapeutic approaches for ...... of pharmacological chaperones

@ast

New therapeutic approaches for ...... of pharmacological chaperones

@en

New therapeutic approaches for ...... of pharmacological chaperones

@nl

type

label

New therapeutic approaches for ...... of pharmacological chaperones

@ast

New therapeutic approaches for ...... of pharmacological chaperones

@en

New therapeutic approaches for ...... of pharmacological chaperones

@nl

prefLabel

New therapeutic approaches for ...... of pharmacological chaperones

@ast

New therapeutic approaches for ...... of pharmacological chaperones

@en

New therapeutic approaches for ...... of pharmacological chaperones

@nl

P1433

Q28068142-9C6E5EB5-FCD6-41A4-AB90-C51C3F948D0D

P1476

Q28068142-F4F43731-26E7-42A9-BAB2-1678CA509AD6

P2093

Q28068142-3C1C651C-684D-4765-832F-38E5F859D87D

P275

Q28068142-4A3CF8D9-61EA-44A8-9E73-65126F022B32

P2860

Q28068142-01141FA5-1532-4A72-BAB5-070AB94BFBAE

Q28068142-0144D87E-A061-4385-9033-FDEC1D7E8517

Q28068142-014B6112-8218-4BE1-97DC-B8BBE485B0F2

Q28068142-06C332DF-4DB1-4B44-A60B-9195BCB1CF44

Q28068142-06D4B65A-EDE7-4213-9736-EE41CEB83F72

Q28068142-08F1C0C5-EB63-40E3-9F83-097FC1270658

Q28068142-0AE50E3B-028D-45A9-B7F0-CC271BF3304A

Q28068142-0B7C4D49-6FCD-4570-9ACD-FFD99ED696E7

Q28068142-117DB631-49F2-4855-ACAB-90C1AEEA764F

Q28068142-135F9B2B-B146-4646-95AC-CDA7225B4329

P304

Q28068142-AA233269-8248-4A8B-ADF4-83738D3E9EB2

P31

Q28068142-6474ED77-9E77-42B2-A6C6-BE15FDCB439A

P3181

Q28068142-EAB9A898-ADB9-427D-B154-C5A1AEC3FC29

P356

Q28068142-19579187-10C6-4C1A-93B8-26018261AC8C

P407

Q28068142-8EDB38ED-693F-4DA1-9454-4B75BF899638

P433

Q28068142-739BC0DC-6062-466F-9F9D-ECEAC5E5AC05

P478

Q28068142-77B64506-2615-4992-AB71-C329B44F3490

P50

Q28068142-A4228F7F-7540-4696-9DD9-15452119E452

P5008

Q28068142-569C7CA3-0F43-4253-ACDB-3E7933488680

P577

Q28068142-8F3D087D-D274-4A07-A4B6-F07632E824A6

P698

Q28068142-6AEBB822-7E9F-47D8-B36E-48BFD261B948

P921

Q28068142-2CED1BDF-4F66-4D67-AA9E-E33D5A8F994D

Q28068142-F75C27D9-9877-4573-A8DE-4DC06DD32D1A

Q28068142-F886C6B4-7622-442A-A5B2-AFCC02EC1A31

P932

Q28068142-BCE2567E-2746-4045-B8FE-861D54739E46

P3181

P356

P1433

Journal of Neuroscience Research

P1476

New therapeutic approaches for ...... of pharmacological chaperones

@en

P2093

Samantha J Spratley

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

The blood-brain barrier: bottleneck in brain drug development

An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay-Sachs or Sandhoff variants)

Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease

Efficient genome editing in zebrafish using a CRISPR-Cas system

Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones

CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases

Endosome maturation

Coumarin and chromen-4-one analogues as tautomerase inhibitors of macrophage migration inhibitory factor: discovery and X-ray crystallography

Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease

Effects of pH and Iminosugar Pharmacological Chaperones on Lysosomal Glycosidase Structure and Stability

P304

1203-1219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2726581

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/JNR.23762

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27638604

http://www.w3.org/2001/XMLSchema#string

P921

molecular chaperones

P932

5031207

http://www.w3.org/2001/XMLSchema#string